Compounds > 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide
Page last updated: 2024-09-03

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Psychomotor Agitation

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Psychomotor Agitation in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baladi, MG; Folk, JE; Jutkiewicz, EM; Rice, KC; Woods, JH1

Other Studies

1 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Psychomotor Agitation

ArticleYear
The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct do
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 324, Issue:2

    Topics: Animals; Benzamides; Central Nervous System Stimulants; Dopamine Agonists; Drug Synergism; Male; Motor Activity; Piperazines; Psychomotor Agitation; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta

2008